Agomab indicated to open at $15.50, IPO priced at $16

1 hour ago 2

Agomab (AGMB) priced 12.5M shares astatine $16.00, wrong the $15.00-$17.00 people range. JPMorgan, Morgan Stanley, Leerink and Kempen are acting arsenic associated publication moving managers for the offering. Agomab is simply a clinical-stage biopharmaceutical institution focused connected processing caller disease-modifying therapies for immunology and inflammatory diseases, with an archetypal absorption connected chronic fibrotic indications with precocious unmet aesculapian need.

Claim 50% Off TipRanks Premium

Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See Insiders’ Hot Stocks connected TipRanks >>

Read More connected AGMB:

Disclaimer & DisclosureReport an Issue